Anti-PTPN4 monoclonal antibody

Pre-made anti-PTPN4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PTPN4/PTPN4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2681-Ab-1/ GM-Tg-hg-IP2681-Ab-2Anti-Human PTPN4 monoclonal antibodyHuman
GM-Tg-rg-IP2681-Ab-1/ GM-Tg-rg-IP2681-Ab-2Anti-Rat PTPN4 monoclonal antibodyRat
GM-Tg-mg-IP2681-Ab-1/ GM-Tg-mg-IP2681-Ab-2Anti-Mouse PTPN4 monoclonal antibodyMouse
GM-Tg-cynog-IP2681-Ab-1/ GM-Tg-cynog-IP2681-Ab-2Anti-Cynomolgus/ Rhesus macaque PTPN4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2681-Ab-1/ GM-Tg-felg-IP2681-Ab-2Anti-Feline PTPN4 monoclonal antibodyFeline
GM-Tg-cang-IP2681-Ab-1/ GM-Tg-cang-IP2681-Ab-2Anti-Canine PTPN4 monoclonal antibodyCanine
GM-Tg-bovg-IP2681-Ab-1/ GM-Tg-bovg-IP2681-Ab-2Anti-Bovine PTPN4 monoclonal antibodyBovine
GM-Tg-equg-IP2681-Ab-1/ GM-Tg-equg-IP2681-Ab-2Anti-Equine PTPN4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2681-Ab-1/ GM-Tg-hg-IP2681-Ab-2; GM-Tg-rg-IP2681-Ab-1/ GM-Tg-rg-IP2681-Ab-2;
GM-Tg-mg-IP2681-Ab-1/ GM-Tg-mg-IP2681-Ab-2; GM-Tg-cynog-IP2681-Ab-1/ GM-Tg-cynog-IP2681-Ab-2;
GM-Tg-felg-IP2681-Ab-1/ GM-Tg-felg-IP2681-Ab-2; GM-Tg-cang-IP2681-Ab-1/ GM-Tg-cang-IP2681-Ab-2;
GM-Tg-bovg-IP2681-Ab-1/ GM-Tg-bovg-IP2681-Ab-2; GM-Tg-equg-IP2681-Ab-1/ GM-Tg-equg-IP2681-Ab-2
Products NameAnti-PTPN4 monoclonal antibody
Formatmab
Target NamePTPN4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PTPN4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2681-Ag-1Recombinant multi-species PTN4/ PTPN4/ MEG protein


    Target information

    Target IDGM-IP2681
    Target NamePTPN4
    Gene ID5775,19258,246116,695516,483882,101081915,512883,100060583
    Gene Symbol and SynonymshPTP-MEG,MEG,Ptn4,PTPMEG,PTPMEG1,PTPN4,TEP,TEP/mPTPMEG
    Uniprot AccessionP29074
    Uniprot Entry NamePTN4_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000088179
    Target ClassificationN/A

    The target: PTPN4, gene name: PTPN4, also named as MEG, PTPMEG, PTPMEG1. The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This protein contains a C-terminal PTP domain and an N-terminal domain homologous to the band 4.1 superfamily of cytoskeletal-associated proteins. This PTP has been shown to interact with glutamate receptor delta 2 and epsilon subunits, and is thought to play a role in signalling downstream of the glutamate receptors through tyrosine dephosphorylation. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.